These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


387 related items for PubMed ID: 30709809

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
    Cartsburg O, Kersten A, Sundmacher R, Nadjari B, Pomjanski N, Böcking A.
    Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Differential diagnosis and prognosis of 112 excised epibulbar epithelial tumors].
    Seitz B, Fischer M, Holbach LM, Naumann GO.
    Klin Monbl Augenheilkd; 1995 Oct; 207(4):239-46. PubMed ID: 8587298
    [Abstract] [Full Text] [Related]

  • 8. The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation.
    Siganos CS, Kozobolis VP, Christodoulakis EV.
    Cornea; 2002 Jan; 21(1):12-6. PubMed ID: 11805500
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of Topical Interferon Alpha-2b Eye Drop as an Adjunctive Therapy Following Surgical Resection in Ocular Surface Squamous Neoplasia.
    Kanaya R, Kase S, Ishijima K, Ishida S.
    In Vivo; 2019 Jan; 33(6):2211-2215. PubMed ID: 31662558
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ocular surface squamous neoplasia in xeroderma pigmentosum: clinical spectrum and outcome.
    Gupta N, Sachdev R, Tandon R.
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1217-21. PubMed ID: 21484462
    [Abstract] [Full Text] [Related]

  • 14. [Malignant epibulbar tumours: new strategies in diagnostics and therapy].
    Westekemper H, Schallenberg M, Tomaszewski A, Nückel H, Sauerwein W, Meller D, Steuhl K.
    Klin Monbl Augenheilkd; 2011 Sep; 228(9):780-92. PubMed ID: 21487989
    [Abstract] [Full Text] [Related]

  • 15. Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection).
    Shields CL, Ramasubramanian A, Mellen PL, Shields JA.
    Ophthalmology; 2011 Nov; 118(11):2133-2137.e1. PubMed ID: 21762990
    [Abstract] [Full Text] [Related]

  • 16. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
    Shields CL, Naseripour M, Shields JA.
    Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
    [Abstract] [Full Text] [Related]

  • 17. Conjunctival pyogenic granuloma during pregnancy.
    Şekkeli MZ, Hoşal MB, Öcal E, Heper A.
    Arq Bras Oftalmol; 2021 May; 84(5):490-493. PubMed ID: 34550219
    [Abstract] [Full Text] [Related]

  • 18. [Actinic keratosis of the conjunctiva. Apropos of a clinical case].
    Mortemousque B, Leger F, Brindeau C, Dorot N, Barac'h D, Verin P.
    J Fr Ophtalmol; 1998 May; 21(6):458-61. PubMed ID: 9759445
    [Abstract] [Full Text] [Related]

  • 19. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
    Akpek EK, Ertoy D, Kalayci D, Hasiripi H.
    Cornea; 1999 Jan; 18(1):59-62. PubMed ID: 9894938
    [Abstract] [Full Text] [Related]

  • 20. Ipsilateral presentation of ocular surface squamous neoplasia and conjunctival melanoma in xeroderma pigmentosum: A rare occurrence.
    Arya D, Das S, Gandhi A.
    Indian J Ophthalmol; 2019 Dec; 67(12):2068-2071. PubMed ID: 31755462
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.